Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Frontiers in Immunology
|
September 25, 2020
Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141<sup>+</sup> Dendritic Cells Induces a Potent Tumor Antigen-Specific Human CD8<sup>+</sup> T Cell Response in Human Immune System Mice
Jing Huang, Jing Zhou, Reem Ghinnagow, et al.
Mbio
|
July 5, 2018
Viral Entry Properties Required for Fitness in Humans Are Lost through Rapid Genomic Change during Viral Isolation
Sho Iketani, Ryan C Shean, Marion Ferren, et al.
Nature Communications
|
April 2, 2021
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
Sho Iketani, Farhad Forouhar, Hengrui Liu, et al.
Iscience
|
November 29, 2023
Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2
Qian Wang, Zhiteng Li, Yicheng Guo, et al.
Biorxiv : the Preprint Server for Biology
|
August 15, 2020
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
Sho Iketani, Farhad Forouhar, Hengrui Liu, et al.
Nature
|
November 9, 2022
Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir
Sho Iketani, Hiroshi Mohri, Bruce Culbertson, et al.
Nature Communications
|
January 3, 2025
Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screening
Hengrui Liu, Arie Zask, Farhad Forouhar, et al.
Biorxiv : the Preprint Server for Biology
|
August 29, 2022
Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir
Sho Iketani, Hiroshi Mohri, Bruce Culbertson, et al.
Cell Host & Microbe
|
August 27, 2022
Functional map of SARS-CoV-2 3CL protease reveals tolerant and immutable sites
Sho Iketani, Seo Jung Hong, Jenny Sheng, et al.
Biorxiv : the Preprint Server for Biology
|
July 21, 2022
The Functional Landscape of SARS-CoV-2 3CL Protease
Sho Iketani, Seo Jung Hong, Jenny Sheng, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Frontiers in Immunology
|
September 25, 2020
Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141<sup>+</sup> Dendritic Cells Induces a Potent Tumor Antigen-Specific Human CD8<sup>+</sup> T Cell Response in Human Immune System Mice
Jing Huang, Jing Zhou, Reem Ghinnagow, et al.
Mbio
|
July 5, 2018
Viral Entry Properties Required for Fitness in Humans Are Lost through Rapid Genomic Change during Viral Isolation
Sho Iketani, Ryan C Shean, Marion Ferren, et al.
Nature Communications
|
April 2, 2021
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
Sho Iketani, Farhad Forouhar, Hengrui Liu, et al.
Iscience
|
November 29, 2023
Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2
Qian Wang, Zhiteng Li, Yicheng Guo, et al.
Biorxiv : the Preprint Server for Biology
|
August 15, 2020
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
Sho Iketani, Farhad Forouhar, Hengrui Liu, et al.
Nature
|
November 9, 2022
Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir
Sho Iketani, Hiroshi Mohri, Bruce Culbertson, et al.
Nature Communications
|
January 3, 2025
Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screening
Hengrui Liu, Arie Zask, Farhad Forouhar, et al.
Biorxiv : the Preprint Server for Biology
|
August 29, 2022
Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir
Sho Iketani, Hiroshi Mohri, Bruce Culbertson, et al.
Cell Host & Microbe
|
August 27, 2022
Functional map of SARS-CoV-2 3CL protease reveals tolerant and immutable sites
Sho Iketani, Seo Jung Hong, Jenny Sheng, et al.
Biorxiv : the Preprint Server for Biology
|
July 21, 2022
The Functional Landscape of SARS-CoV-2 3CL Protease
Sho Iketani, Seo Jung Hong, Jenny Sheng, et al.
Page
of 5